Immature teratomas: Identification of patients at risk for malignant recurrence

Marcio Malogolowkin, Jorge A. Ortega, Mark Krailo, Orlando Gonzalez, G. Hossein Mahour, Benjamin H. Landing, Stuart E. Siegel

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

We investigated the significance of immature elements in an otherwise benign teratoma in 28 patients with immature teratomas diagnosed and treated at the Childrens Hospital of Los Angeles from 1941 to 1986. Different characteristics, including age, sex, primary tumor site, type of surgery (complete resection vs. partial resection or biopsy), and preoperative levels of alpha-fetoprotein (AFP) were analyzed to evaluate their association with risk of subsequent local malignant recurrence. After a median follow-up of 6 years, 21 patients are alive with no recurrence of the tumor (72% event-free survival). One patient died from infection after surgery and six patients had local malignant tumor recurrence within 1 year from diagnosis. Of the 28 patients, 12 had AFP levels measured at diagnosis. Eight patients had normal levels with no further evidence of tumor recurrence, and four had elevated levels with three tumor recurrences. Our experience demonstrates that only at the time of diagnosis do AFP levels correlate with a subsequent malignant behavior of these tumors (P = .004). Those patients with immature teratomas and elevated AFP levels at diagnosis should receive adjuvant chemotherapy after the initial surgical resection [J Natl Cancer Inst 81:870-874, 1989]

Original languageEnglish (US)
Pages (from-to)870-875
Number of pages6
JournalJournal of the National Cancer Institute
Volume81
Issue number11
DOIs
StatePublished - Jun 7 1989
Externally publishedYes

Fingerprint

Teratoma
Recurrence
alpha-Fetoproteins
Neoplasms
Los Angeles
Adjuvant Chemotherapy
Disease-Free Survival
Biopsy
Infection

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Malogolowkin, M., Ortega, J. A., Krailo, M., Gonzalez, O., Mahour, G. H., Landing, B. H., & Siegel, S. E. (1989). Immature teratomas: Identification of patients at risk for malignant recurrence. Journal of the National Cancer Institute, 81(11), 870-875. https://doi.org/10.1093/jnci/81.11.870

Immature teratomas : Identification of patients at risk for malignant recurrence. / Malogolowkin, Marcio; Ortega, Jorge A.; Krailo, Mark; Gonzalez, Orlando; Mahour, G. Hossein; Landing, Benjamin H.; Siegel, Stuart E.

In: Journal of the National Cancer Institute, Vol. 81, No. 11, 07.06.1989, p. 870-875.

Research output: Contribution to journalArticle

Malogolowkin, M, Ortega, JA, Krailo, M, Gonzalez, O, Mahour, GH, Landing, BH & Siegel, SE 1989, 'Immature teratomas: Identification of patients at risk for malignant recurrence', Journal of the National Cancer Institute, vol. 81, no. 11, pp. 870-875. https://doi.org/10.1093/jnci/81.11.870
Malogolowkin, Marcio ; Ortega, Jorge A. ; Krailo, Mark ; Gonzalez, Orlando ; Mahour, G. Hossein ; Landing, Benjamin H. ; Siegel, Stuart E. / Immature teratomas : Identification of patients at risk for malignant recurrence. In: Journal of the National Cancer Institute. 1989 ; Vol. 81, No. 11. pp. 870-875.
@article{781061168d354731aefa24606c45e524,
title = "Immature teratomas: Identification of patients at risk for malignant recurrence",
abstract = "We investigated the significance of immature elements in an otherwise benign teratoma in 28 patients with immature teratomas diagnosed and treated at the Childrens Hospital of Los Angeles from 1941 to 1986. Different characteristics, including age, sex, primary tumor site, type of surgery (complete resection vs. partial resection or biopsy), and preoperative levels of alpha-fetoprotein (AFP) were analyzed to evaluate their association with risk of subsequent local malignant recurrence. After a median follow-up of 6 years, 21 patients are alive with no recurrence of the tumor (72{\%} event-free survival). One patient died from infection after surgery and six patients had local malignant tumor recurrence within 1 year from diagnosis. Of the 28 patients, 12 had AFP levels measured at diagnosis. Eight patients had normal levels with no further evidence of tumor recurrence, and four had elevated levels with three tumor recurrences. Our experience demonstrates that only at the time of diagnosis do AFP levels correlate with a subsequent malignant behavior of these tumors (P = .004). Those patients with immature teratomas and elevated AFP levels at diagnosis should receive adjuvant chemotherapy after the initial surgical resection [J Natl Cancer Inst 81:870-874, 1989]",
author = "Marcio Malogolowkin and Ortega, {Jorge A.} and Mark Krailo and Orlando Gonzalez and Mahour, {G. Hossein} and Landing, {Benjamin H.} and Siegel, {Stuart E.}",
year = "1989",
month = "6",
day = "7",
doi = "10.1093/jnci/81.11.870",
language = "English (US)",
volume = "81",
pages = "870--875",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Immature teratomas

T2 - Identification of patients at risk for malignant recurrence

AU - Malogolowkin, Marcio

AU - Ortega, Jorge A.

AU - Krailo, Mark

AU - Gonzalez, Orlando

AU - Mahour, G. Hossein

AU - Landing, Benjamin H.

AU - Siegel, Stuart E.

PY - 1989/6/7

Y1 - 1989/6/7

N2 - We investigated the significance of immature elements in an otherwise benign teratoma in 28 patients with immature teratomas diagnosed and treated at the Childrens Hospital of Los Angeles from 1941 to 1986. Different characteristics, including age, sex, primary tumor site, type of surgery (complete resection vs. partial resection or biopsy), and preoperative levels of alpha-fetoprotein (AFP) were analyzed to evaluate their association with risk of subsequent local malignant recurrence. After a median follow-up of 6 years, 21 patients are alive with no recurrence of the tumor (72% event-free survival). One patient died from infection after surgery and six patients had local malignant tumor recurrence within 1 year from diagnosis. Of the 28 patients, 12 had AFP levels measured at diagnosis. Eight patients had normal levels with no further evidence of tumor recurrence, and four had elevated levels with three tumor recurrences. Our experience demonstrates that only at the time of diagnosis do AFP levels correlate with a subsequent malignant behavior of these tumors (P = .004). Those patients with immature teratomas and elevated AFP levels at diagnosis should receive adjuvant chemotherapy after the initial surgical resection [J Natl Cancer Inst 81:870-874, 1989]

AB - We investigated the significance of immature elements in an otherwise benign teratoma in 28 patients with immature teratomas diagnosed and treated at the Childrens Hospital of Los Angeles from 1941 to 1986. Different characteristics, including age, sex, primary tumor site, type of surgery (complete resection vs. partial resection or biopsy), and preoperative levels of alpha-fetoprotein (AFP) were analyzed to evaluate their association with risk of subsequent local malignant recurrence. After a median follow-up of 6 years, 21 patients are alive with no recurrence of the tumor (72% event-free survival). One patient died from infection after surgery and six patients had local malignant tumor recurrence within 1 year from diagnosis. Of the 28 patients, 12 had AFP levels measured at diagnosis. Eight patients had normal levels with no further evidence of tumor recurrence, and four had elevated levels with three tumor recurrences. Our experience demonstrates that only at the time of diagnosis do AFP levels correlate with a subsequent malignant behavior of these tumors (P = .004). Those patients with immature teratomas and elevated AFP levels at diagnosis should receive adjuvant chemotherapy after the initial surgical resection [J Natl Cancer Inst 81:870-874, 1989]

UR - http://www.scopus.com/inward/record.url?scp=0024399717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024399717&partnerID=8YFLogxK

U2 - 10.1093/jnci/81.11.870

DO - 10.1093/jnci/81.11.870

M3 - Article

C2 - 2470911

AN - SCOPUS:0024399717

VL - 81

SP - 870

EP - 875

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 11

ER -